雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Therapeutic Strategies for Myasthenia Gravis Hiroyuki Murai 1 1Department of Neurology, International University of Health and Welfare Keyword: 重症筋無力症 , ステロイド , 免疫抑制薬 , 早期速効性治療戦略 , 分子標的薬 , myasthenia gravis , steroids , immunosuppressants , early fast-acting treatment , molecular targeted drugs pp.527-532
Published Date 2023/5/1
DOI https://doi.org/10.11477/mf.1416202372
  • Abstract
  • Look Inside
  • Reference

Abstract

For years, the treatment of myasthenia gravis (MG) included high-dose oral steroids. This improved the mortality rate, but the adverse aspects of this treatment have become apparent. To overcome these statuses, an early fast-acting treatment strategy was advocated in the 2010s. Although this strategy improved the patients' quality of life, there are still many patients experiencing impaired activities of daily living. A certain number of so-called “refractory MG” patients also exist. Molecular-targeted drugs for MG have recently been developed. To date, three such drugs are available in Japan.


Copyright © 2023, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有